These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6757974)

  • 61. Prostacyclin in experimental ischemic models.
    Awad IA
    Stroke; 1989 May; 20(5):698-9. PubMed ID: 2655189
    [No Abstract]   [Full Text] [Related]  

  • 62. Prostacyclin infusion in patients with acute myocardial infarction (preliminary report).
    Edhag O; Henriksson P; Wennmalm A
    N Engl J Med; 1983 Apr; 308(17):1032-3. PubMed ID: 6339931
    [No Abstract]   [Full Text] [Related]  

  • 63. Prostacyclin and prostaglandin E1 for severe idiopathic pulmonary artery hypertension.
    Watkins WD; Peterson MB; Crone RK; Shannon DC; Levine L
    Lancet; 1980 May; 1(8177):1083. PubMed ID: 6103414
    [No Abstract]   [Full Text] [Related]  

  • 64. Intermittent epoprostenol (prostacyclin) infusion in patients with Raynaud's syndrome. A double-blind controlled trial.
    Belch JJ; Newman P; Drury JK; McKenzie F; Capell H; Leiberman P; Forbes CD; Prentice CR
    Lancet; 1983 Feb; 1(8320):313-5. PubMed ID: 6130329
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Platelet proteins during and after prostacyclin therapy for lower limb ischaemia--suggestion of a rebound platelet activation.
    Blättler W; Furrer K; Schriber K; Kofmehl R; Massini C
    Vasa; 1981; 10(3):261-3. PubMed ID: 6169225
    [No Abstract]   [Full Text] [Related]  

  • 66. Prostacyclin and atherosclerosis.
    Szczeklik A
    Triangle; 1980; 19(2):61-7. PubMed ID: 7003851
    [No Abstract]   [Full Text] [Related]  

  • 67. Treatment of pregnancy hypertension with prostacyclin.
    Fidler J; Bennett MJ; de Swiet M; Ellis C; Lewis PJ
    Lancet; 1980 Jul; 2(8184):31-2. PubMed ID: 6104235
    [No Abstract]   [Full Text] [Related]  

  • 68. Prostacyclin in Falciparum malaria.
    Weston MJ; Jackman N; Rudge C; Bowles J; Brady C; Bielawska C; O'Grady J
    Lancet; 1982 Sep; 2(8298):609. PubMed ID: 6125752
    [No Abstract]   [Full Text] [Related]  

  • 69. Paradoxical behaviour of antithrombin III during hemodialysis and its prevention with prostacyclin.
    Turney JH; Fewell M; Williams LC; Dodd N; Weston MJ
    Clin Nephrol; 1982 Jan; 17(1):31-5. PubMed ID: 7035043
    [No Abstract]   [Full Text] [Related]  

  • 70. Successful therapy of advanced arteriosclerosis obliterans with prostacyclin.
    Szczeklik A; Nizankowski R; Skawinski S; Szczeklik J; Gluszko P; Gryglewski RJ
    Lancet; 1979 May; 1(8126):1111-4. PubMed ID: 86835
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prostacyclin infusion in haemolytic-uraemic syndrome of children.
    Beattie TJ; Murphy AV; Willoughby ML; Belch JJ
    Br Med J (Clin Res Ed); 1981 Aug; 283(6289):470. PubMed ID: 6790019
    [No Abstract]   [Full Text] [Related]  

  • 72. Prostacyclin in central retinal vein occlusion.
    Zygulska-Mach H; Kostka-Trabka E; Nitoń A; Gryglewski RJ
    Lancet; 1980 Nov; 2(8203):1075. PubMed ID: 6107692
    [No Abstract]   [Full Text] [Related]  

  • 73. Prostacyclin as the sole antithrombotic agent for acute renal failure hemodialysis.
    Hory B; Saint-Hillier Y; Perol JC
    Nephron; 1983; 33(1):71. PubMed ID: 6339968
    [No Abstract]   [Full Text] [Related]  

  • 74. Rationale and proposal for use of prostacyclin in thrombotic thrombocytopenic purpura therapy.
    Cocchetto DM; Cook L; Cato AE; Niedel JE
    Semin Thromb Hemost; 1981; 7(1):43-51. PubMed ID: 7015516
    [No Abstract]   [Full Text] [Related]  

  • 75. Some remarks on the complex behaviour of platelet function during and after prostacyclin treatment.
    Sinzinger H; Silberbauer K; Leithner C; Schwarz M
    Vasa; 1981; 10(4):348-9. PubMed ID: 7032112
    [No Abstract]   [Full Text] [Related]  

  • 76. [PGI2 therapy in congestive heart failure and its effects on the sympathetic nervous activity].
    Yui Y; Nakajima H; Wakabayashi A; Kawai C
    Kokyu To Junkan; 1983 Jan; 31(1):59-61. PubMed ID: 6344169
    [No Abstract]   [Full Text] [Related]  

  • 77. Use of prostacyclin in persistent fetal circulation.
    Lock JE; Olley PM; Coceani F; Swyer PR; Rowe RD
    Lancet; 1979 Jun; 1(8130):1343. PubMed ID: 87797
    [No Abstract]   [Full Text] [Related]  

  • 78. Epoprostenol and severe arterial disease.
    Olsson AG
    Lancet; 1983 Mar; 1(8326 Pt 1):711-2. PubMed ID: 6132070
    [No Abstract]   [Full Text] [Related]  

  • 79. Reversal of oleic acid-induced respiratory distress by prostacyclin (PGI2).
    Miyazawa T; Hiramoto M; Hiramoto T; Nishida O
    Respir Physiol; 1982 Mar; 47(3):351-64. PubMed ID: 6808627
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prostacyclin: a potent antimetastatic agent.
    Honn KV; Cicone B; Skoff A
    Science; 1981 Jun; 212(4500):1270-2. PubMed ID: 7015512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.